Published in J Clin Pathol on December 01, 1987
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody. Lancet (1982) 5.63
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer (1981) 3.90
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer (1985) 1.76
Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol (1982) 1.74
THE EXFOLIATIVE CYTOLOGY OF DIFFUSE MALIGNANT MESOTHELIOMA. J Pathol Bacteriol (1963) 1.46
Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer (1979) 1.43
Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol (1987) 1.41
Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia. J Clin Pathol (1983) 1.39
Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium. J Clin Pathol (1984) 1.34
Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol (1982) 1.28
Human lung tumours: a correlation of antigenic profile with histological type. Histopathology (1985) 1.22
Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology (1984) 1.16
Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions. Cancer (1985) 1.06
Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Acta Cytol (1982) 0.98
Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study. Am J Clin Pathol (1983) 0.86
Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions. J Clin Pathol (1985) 0.79
The use of electron microscopy in the diagnosis of diffuse mesotheliomas using human pleural effusions. IARC Sci Publ (1980) 0.78
Cervical intraepithelial neoplasia. J Clin Pathol (1982) 5.85
Condylomatous lesions of the lower female genital tract. Clin Obstet Gynaecol (1984) 3.17
Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis (2013) 3.07
Quality control in cervical cytology. J Clin Pathol (1974) 2.71
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2001) 1.42
Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol (1998) 1.19
Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys (2001) 1.07
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. J Urol (2000) 1.04
Demonstration of papilloma virus particles in cervical and vaginal scrape material: a report of 10 cases. J Clin Pathol (1981) 1.02
The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otorhinolaryngol (2000) 0.99
Problems in cervicovaginal cytology: fine structure as an aid to diagnosis. Acta Cytol (1980) 0.99
A teleradiology case conference system. J Telemed Telecare (1995) 0.98
High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol Biol Phys (1996) 0.98
Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. Oncologist (1999) 0.97
Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys (2001) 0.96
Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy. J Neuroophthalmol (1996) 0.95
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy. Hum Gene Ther (2001) 0.95
Compliance with screening for colorectal cancer. Br Med J (Clin Res Ed) (1986) 0.93
A comparison of intensity modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions. Int J Radiat Oncol Biol Phys (1996) 0.91
Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer. Mol Ther (2001) 0.91
Combined external quality assessment of cytology and histology opinions: a pilot scheme for a cluster of five laboratories. J Clin Pathol (1984) 0.90
Method for the removal of selected cells from cytological smear preparations for transmission electron microscopy. J Clin Pathol (1981) 0.89
Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model. Int J Radiat Oncol Biol Phys (2001) 0.85
Intensity modulated radiation therapy (IMRT) in the management of prostate cancer. Cancer Invest (2004) 0.83
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer. Gene Ther (2006) 0.83
Perineal prostatic cancer seeding following radioactive seed brachytherapy. J Urol (2001) 0.82
Human papillomavirus infection of the lower female genital tract: association with multicentric neoplasia. Int J Gynecol Pathol (1983) 0.81
The potential use of intensity modulated radiotherapy (IMRT) in women with pectus excavatum desiring breast-conserving therapy. Breast J (2001) 0.81
A micro-method for the determination of serum iron and total iron-binding capacity and its application in pregnancy. Clin Chim Acta (1966) 0.81
Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy. Int J Radiat Oncol Biol Phys (2001) 0.81
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report. Int J Radiat Oncol Biol Phys (2001) 0.80
Comment on "Reporting and analyzing dose distributions: a concept of equivalent uniform dose" [Med. Phys. 24, 103-109 (1997)]. Med Phys (1997) 0.80
The field-matching problem as it applies to the peacock three dimensional conformal system for intensity modulation. Int J Radiat Oncol Biol Phys (1996) 0.80
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene. World J Urol (2000) 0.79
Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer. Cancer Gene Ther (2013) 0.79
The use of electron microscopy in the diagnosis of diffuse mesotheliomas using human pleural effusions. IARC Sci Publ (1980) 0.78
Vulvar intraepithelial neoplasia and microinvasive carcinoma of the vulva. J Clin Pathol (1984) 0.78
Effect of iron and folic acid on red cell and plasma volume in pregnancy. J Obstet Gynaecol Br Commonw (1968) 0.78
Quantitative DNA analysis of low grade cervical intraepithelial neoplasia and human papillomavirus infection by static and flow cytometry. Br Med J (Clin Res Ed) (1987) 0.77
Treatment of secretory pituitary adenoma with radiation therapy. Radiology (1993) 0.77
The application of protein microarrays to serum diagnostics: prostate cancer as a test case. Dis Markers (2001) 0.76
The postnatal smear. Acta Cytol (1973) 0.76
Quantitative deoxyribonucleic acid analysis of patients with mild cervical atypia: a potentially malignant lesion? Obstet Gynecol (1987) 0.76
Does the "peacock" have anything to do with radiotherapy? Int J Radiat Oncol Biol Phys (1994) 0.76
Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Ear Nose Throat J (1999) 0.76
Cervical screening in the inner cities: is the opportunistic approach still worthwhile? BMJ (1996) 0.75
Intercultural consultations. Multilingual literature is useful. BMJ (1995) 0.75
Costs and benefits of cervical screening. Cytopathology (1997) 0.75
Clinical realization of 3D conformal intensity modulated radiotherapy: regarding Bortfeld et al., IJROBP 30:899-908; 1994. Int J Radiat Oncol Biol Phys (1995) 0.75
In response to Drs. Goitein and Niemierko. Int J Radiat Oncol Biol Phys (1997) 0.75
Fractionated high-dose rate brachytherapy for intracranial gliomas. Int J Radiat Oncol Biol Phys (1994) 0.75
Kuper brush in the diagnosis of endometrial lesions. Lancet (1971) 0.75
An analysis of the variation of human interpretation: Papnet a mini-challenge. Anal Cell Pathol (1994) 0.75
The early diagnosis of cancer of the endometrium. Clin Obstet Gynaecol (1976) 0.75
The European Federation of Cytology Societies, 1969-1989. Acta Cytol (1992) 0.75
A micro-method for the estimation of blood volume. Clin Chim Acta (1966) 0.75
Ultrasound guided placement of transperineal prostatic afterloading catheters. Int J Radiat Oncol Biol Phys (1994) 0.75
Quantitative ultrastructural study of nuclei from exfoliated benign and malignant mesothelial cells and metastatic adenocarcinoma cells. Acta Cytol (1986) 0.75
Is there a future for clinical cytology? Br Med J (1979) 0.75
Ectopic production of salivary type amylase by a pseudomesotheliomatous carcinoma of the lung. Cancer (1978) 0.75
Intranasal stent for stabilization and fixation of interstitial radioactive isotopes. J Prosthet Dent (1991) 0.75
PAPNET. The human and other dimensions. Acta Cytol (1997) 0.75
Training in cervical cytology. Cytopathology (1999) 0.75
Retention of Chromium by Glass Following Treatment with Cleaning Solution. Science (1954) 0.75
Cytopathology in the United Kingdom: 1854 to the present. Diagn Cytopathol (2000) 0.75